+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Convallatoxin

BP0389
508-75-8
98%
Biopurify
Convallatoxin is a cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3. It has a role as a metabolite and a vasodilator agent. It is a steroid aldehyde, a steroid lactone, an alpha-L-rhamnoside, a 14beta-hydroxy steroid, a 19-oxo steroid and a 5beta-hydroxy steroid. It is functionally related to a strophanthidin. Convallatoxin, one cardiac glycoside, is a novel anti-angiogenic compound via dual inducing of autophagy and apoptosis, it shows antitumor effects that harbor inactivating mutations in the p53 signaling pathway. Convallatoxin as a novel antiviral, limiting mRNA translation has a dramatic impact on CMV infection and proliferation. Convallatoxin also anti-diabetic activity.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0389-10mg 10mg
BP0389-20mg 20mg
BP0389-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

ABCB1 PRKCA TNF PPARG PTGS2 NFKB1 IL6 IL1B RYR2
TNF PPARG PTGS2 NFKB1 IL6 IL1B
PRKCA OPRM1 GRIN1

Convallatoxin Related Products

Product drug property prediction parameters

  • 189.6900

  • .1900

  • No

  • No

  • No

  • Yes

  • Unknown

  • No

  • Unknown